The use of proteasome inhibitors in anti-cancer therapy
DOI: http://dx.doi.org/10.12775/JEHS.2020.10.07.026
Abstract
Proteins are the basic building blocks of the human body. Most proteins, after fulfilling their function, are degraded with the help of a multi-catalytic proteolytic complex - the 26S proteasome, thanks to its prior labeling with a poly-ubiquitin chain. The ubiquitin-proteasome complex is involved in the control of many important cellular processes. It is involved in the cell cycle, cell proliferation and growth, apoptosis, control of receptor function, quality of proteins in the endoplasmic reticulum, immune response, stress response and other extracellular factors. The dysfunction of the ubiquitin-proteasome pathway plays an important role in the development of many neurodegenerative and neoplastic diseases, as well as diseases with an immune and infectious origin. Accordingly, research is being conducted where the UPS complex is the target of therapeutic activities. Specific proteasome inhibitors are used in cancer therapy. The first to be approved by the FDA was bortezomib, which is a peptide derivative of boric acid. It has the ability to initiate the process of apoptosis by inhibiting the activity of the NF-κB protein, which is a transcription factor. This compound is used in the treatment of multiple myeloma and malignant lung and breast cancers. There are also studies on the combination of proteasome inhibitors with other chemotherapeuticam. There is still growing interest in research aimed at obtaining substances that allowed to control the mechanisms of proteolytic degradation.
Keywords
Full Text:
PDFReferences
Podgórska J., Komórkowy system sprzątający – degradacja proteasomalna i jej rola w terapii onkologicznej, Biotechnologia.pl, 2017
M. Staszczak (2017), Szalak ubikwityna- proteasom, jako cel strategii terapeutycznych, Postępy Biochemii 53 (4), 289-291
Bubko I. i inni, Rola proteasomu w terapii chorób nieuleczalnych, Postepy Hig Med Dosw., 2010; 64: 314-325
Maliński M., Cichocki M., Inhibicja aktywności proteasomu, jako nowa strategia w terapii i chemioprewencji nowotworów, Postepy Hig Med Dosw 2013; 67 : 90-106
N. M. Weathington, R. K. Mallampalli (2014), Emerging therapies targeting the ubiquitin
proteasome system in cancer, The Journal of Clinical Investigation, 124,1
Dees E.C, Orlowski R.Z., 2006, Targeting the ubiquitin–proteasome pathway in breast cancer therapy, Future Oncol. (2006) 2(1), 122
Kazula A., Kazula E., Proteasomy a nowe kierunki terapii, Terapia i Leki., (2009)., tom 65, nr.7
Henshall F.N., Kumar S. T, Ubiquitination and the regulation of membrane proteins. Physiol. Rev. (2017). 97: 253-281
Stój J., Karpowicz P., Proteolityczny kombinat i jego regulatory, Wiadomości chemiczne, (2012), 66
Romaniuk R. i inni, Inhibitory proteasomów w terapii onkologicznej, Postepy Hig Med Dosw., (2015) 69: 1443-1450
Article Metrics
Metrics powered by PLOS ALM
Journal of Education, Health and Sport formerly Journal of Health Sciences
Declaration on the original version.
Editors indicates that the main version of the magazine is to issue a "electronic".
The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.
1223 Journal of Education, Health and Sport eISSN 2391-8306 7
ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X
Archives 2011 - 2014
PBN 2011 - 2014
https://pbn.nauka.gov.pl/sedno-webapp/search?search&searchCategory=WORK&filter.inJournal=36616
POL-index 2011 - 2014
https://pbn.nauka.gov.pl/polindex-webapp/browse/journal/journal-32a319c5-a850-4f44-ba70-1418a6087655
BASE 2011 - 2014
http://elibrary.ru/contents.asp?titleid=37467
http://journal.rsw.edu.pl/index.php/JHS/issue/archive
Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska, EuroPub database, NLM Catalog Result - NCBI, BASE, Russian Sciences Index, Arianta.
https://zdb-katalog.de/title.xhtml?idn=1080187162
https://europub.co.uk/journals/22625
US NLM = 101679844
101679844 - NLM Catalog Result - NCBI
https://www.ncbi.nlm.nih.gov/nlmcatalog/101679844
Find a library that holds this journal: http://worldcat.org/issn/23918306
PBN Poland
https://pbn.nauka.gov.pl/sedno-webapp/journals/49068
POL-index
https://pbn.nauka.gov.pl/polindex-webapp/browse/journal/journal-c39c8169-88d2-45db-9e7f-d948ce9981c4
BASE
Redaction, Publisher and Editorial Office
Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X
The journal has been approved for inclusion in ERIH PLUS.
The ERIH PLUS listing of the journal is available at https://dbh.nsd.uib.no/publiseringskanaler/erihplus/periodical/info?id=485984
Indexed in Index Copernicus Journals Master List.
http://journals.indexcopernicus.com/Journal+of+Education+Health+and+Sport,p24782242,3.html
ICV 2019 = 100.00 ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 2011: 5.48
RG Journal Impact: 0.18 *
RG Journal impact history
2020 | Available summer 2021 |
---|---|
2018 / 2019 | 0.18 |
2017 | 0.07 |
2016 | 0.03 |
RG Journal impact over time
Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (https://pbn.nauka.gov.pl/journals/36616)
is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.
Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ) http://elibrary.ru/contents.asp?titleid=37467
Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski
(http://www1.bg.us.edu.pl/bazy/czasopisma/czasop_full.asp?id=3595)